MARKET

SNN

SNN

Smith & Nephew
NYSE

Real-time Quotes | Nasdaq Last Sale

44.01
+0.14
+0.32%
Closed 16:00 06/14 EDT
OPEN
43.71
PREV CLOSE
43.87
HIGH
44.01
LOW
43.55
VOLUME
241.06K
TURNOVER
--
52 WEEK HIGH
46.10
52 WEEK LOW
34.29
MARKET CAP
19.34B
P/E (TTM)
43.21
1D
5D
1M
3M
1Y
5Y
Smith & Nephew Upgraded by Credit Suisse to Outperform From Neutral, Price Target Raised to GBP18.05 From GBP15.60
MT Newswires · 6d ago
UPDATE 1-Mining, financial stocks drag FTSE 100 lower; Clinigen Group tumbles
reuters.com · 6d ago
UPDATE 2-British shares end lower as mining, financial stocks weigh
reuters.com · 6d ago
Mining, insurance stocks drag FTSE 100 lower; Smith+Nephew outperforms
reuters.com · 6d ago
Medical Robots Market Revenue to Cross USD 22.1 Bn by 2027: Global Market Insights Inc.
, /PRNewswire/ -- According to the latest report  by Global Market Insights Inc., the  will cross by 2027.
PR Newswire - PRF · 06/02 10:00
Surgical Robots Market Global Industry Size, Growth, Manufacturers, Segments and Forecast Report
Japan, Japan, Wed, 26 May 2021 02:23:43 / Comserve Inc. / -- Surgical Robots Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies, Tendencies and Forecast
Comserve · 05/26 06:25
Healthcare Robotics Market Current Trends, Segmentation, Key Players and Analysis
Japan, Japan, Wed, 26 May 2021 02:23:36 / Comserve Inc. / -- Healthcare Robotics Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies, Tendencies and Forecast
Comserve · 05/26 06:25
Diabetic Foot Ulcer Treatment Market Worth USD 11.05 Billion at 5.9% CAGR; Rising Adoption of Novel Wound Care Devices to Propel Growth: Fortune Business Insights(TM)
The global "diabetic foot ulcer treatment market" size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes followed by a foot ulcer. A diabetic foot ulcer is an open wound occurring in the sole of the feet of a di...
GlobeNewswire · 05/25 10:04
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SNN. Analyze the recent business situations of Smith & Nephew through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SNN stock price target is 50.17 with a high estimate of 55.00 and a low estimate of 46.50.
EPS
Institutional Holdings
Institutions: 377
Institutional Holdings: 49.01M
% Owned: 11.15%
Shares Outstanding: 439.55M
TypeInstitutionsShares
Increased
90
3.40M
New
37
1.29M
Decreased
58
1.61M
Sold Out
24
439.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.36%
Healthcare Equipment & Supplies
+0.39%
Key Executives
Non-Executive Chairman/Independent Director
Roberto Quarta
Chief Executive Officer/Executive Director
Roland Diggelmann
Chief Financial Officer/Executive Director
Anne-Francoise Nesmes
Corporate Executive
Brad Cannon
Corporate Executive
Peter Coenen
Corporate Executive
Myra Eskes
Corporate Executive
Simon Fraser
Corporate Executive
Mark Gladwell
Corporate Executive
Skip Kiil
Corporate Executive
Vasant Padmanabhan
Chief Human Resource Officer
Elga Lohler
Chief Compliance Officer
Catheryn O'Rourke
Chief Compliance Officer
Cathy O'Rourke
Other
Phil Cowdy
Other
Melissa Guerdan
Secretary
Susan Swabey
Non-Executive Independent Director
Erik Engstrom
Non-Executive Independent Director
Robin Freestone
Non-Executive Independent Director
John Ma
Non-Executive Independent Director
Katarzyna Mazur-Hofsaess
Non-Executive Independent Director
Rick Medlock
Non-Executive Independent Director
Marc Owen
Non-Executive Independent Director
Angie Risley
Non-Executive Independent Director
Bob White
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.452
04/05/2021
07/29/2020
Dividend USD 0.278
10/01/2020
--
Dividend USD 0.452
04/02/2020
--
Dividend USD 0.278
10/03/2019
--
Dividend USD 0.43
04/04/2019
--
Dividend USD 0.27
10/04/2018
02/08/2018
Dividend USD 0.444
04/05/2018
08/28/2017
Dividend USD 0.236
10/05/2017
02/27/2017
Dividend USD 0.37
03/29/2017
09/01/2016
Dividend USD 0.236
10/05/2016
02/08/2016
Dividend USD 0.37
04/20/2016
08/31/2015
Dividend USD 0.226
10/07/2015
04/17/2015
Dividend USD 0.372
04/15/2015
10/14/2014
Dividend USD 0.22
10/22/2014
02/19/2014
Dividend USD 0.83
04/17/2014
08/27/2013
Dividend USD 0.51
10/09/2013
03/08/2013
Dividend USD 0.79
04/17/2013
  • All
  • Financials
  • Insiders
More
About SNN
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Webull offers kinds of Smith & Nephew plc (ADR) stock information, including NYSE:SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.